Triglyceriden zijn vetten (esters van glycerol en drie vetzuren) die in het lichaam voornamelijk worden gebruikt als energiebron in spierweefsel; ze circuleren in het bloed in de vorm van lipoproteïnen en worden opgeslagen in vetweefsel. Een verhoogde triglyceridenbloedspiegel (met name de niet-nuchtere spiegel) is geassocieerd met toename van atherosclerose (via atherogene triglyceridenrijke lipoproteïnen remnants en apo CIII) en is waarschijnlijk een onafhankelijke risicofactor voor hart- en vaatziekten, met name bij vrouwen.1,2
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Figuren
Verschenen in
Referenties
1. Miller M et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011;123:2292-2333.
2. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 1986;112:432-437.
3. Mazza A et al. Triglycerides, highdensity-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Intern Med J. 2005;35:604–610.
4. Smelt AH. Triglycerides and gallstone formation. Clinica Chimica Acta 2010;411:1625-1631.
5. Ray JG et al. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006;113:379–386.
6. Hou R et al. A case of severe neuropathy associated with hypertriglyceridemia. Endocrine Practice. 2008;14(8):1020-1022.
7. Van Gaal LF et al. What is the relationship between risk factor reduction and degree of weight loss? Eur Heart J Suppl. 2005;7(suppl L):L21–L26.
8. Durstine JL et al. Lipids, lipoproteins, and exercise. J Cardiopulm Rehabil. 2002;22:385–398.
9. Anderson JW et al. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
10. Erdman Jr JW. AHA Science Advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000;102:2555-9.
11. Kris-Etherton PM et al; American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757.
12. De Caterina R. N-3 fatty acids in cardiovascular disease. N Engl J Med 2011;364(25):2439-50.
13. Balk E et al. Effects of Omega-3 Fatty Acids on Cardiovascular Risk Factors and Intermediate Markers of Cardiovascular Disease. Evidence Report/ Technology Assessment No. 93 (prepared by Tufts-New England Medical Center Evidence-Based Practice Center under contract No. 290-02-0022). AHRQ publication No. 04-E010-2. Rockville, MD: Agency for Healthcare Research and Quality; 2004.
14. Hauenschild A, Bretzel RG, Schnell-Kretschmer H, et al. Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides. Ann Nutr Metab. 2010;56(3):170-5.
15. Ylonen K et al. Associations of dietary fiber with glucose metabolism in nondiabetic relatives of subjects with type 2 diabetes: the Botnia Dietary Study. Diabetes Care. 2003;26:1979 –1985.
16. Sola R et al. Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial. Atherosclerosis 2010;211:630-637.
17. Larrieta E et al. Pharmacological concentrations of biotin reduce serum triglycerides and the expression of lipogenic genes. Eur J Pharmacol. 2010;644:263-268.
18. Revilla-Monsalve C et al. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. Biomed Pharmacother. 2006;60:182-185.
19. Geohas J et al. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci. 2007;333:145-153.
20. Cicero AF et al. Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. Biomedicine & Pharmacotherapy 59 (2005) 312–317.
21. Singh RB et al. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 1999;13(3):203-8.
22. Wanga J et al. Multicenter clinical trial of the serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr Ther Res 1997;58:964-78.
23. Li JM et al. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology. 2010;51(5):1555-66.
24. Kianbakht S et al. Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double‐blind placebo‐controlled clinical trial. Phytother Res. 2011 Apr 19. doi: 10.1002/ptr.3506.
25. Aramwit P et al. Efficacy of mulberry leaf tablets in patients with mild dyslipidemia. Phytother Res. 2011;25: 365–369.
26. Ngo MQ et al. Oral Aloe Vera for Treatment of Diabetes Mellitus and
Dyslipidemia. American Journal of Health-System Pharmacy. 2010;67(21):1804-1811.
27. Unno T et al. Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br J Nutr. 2005;93(4):543-7.
